Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CKPT will rise by +2.18% over the next 2 Weeks and hit $4.35 by Friday, June 13, 2025. In that time frame, CKPT's share price is expected to range between $4.30 and $4.41.
BearishAverageBullishCKPT shares remained flat 0 in Friday, May 30, 2025's trading session, starting and closing at a previous close of $4.26 to move at $4.26. The stock demonstrated notable intraday movement (see CKPT's key stats for a full breakdown), fluctuating between $4.24 and $4.26, a +0.47% trading range. While recent weeks have seen some volatility, CKPT has managed to secure a +2.65% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 8.63M shares changing hands, 514 more than the previous session. This amounted to $36.77M in total market activity.
Will CKPT Continue Its Upward Trend?
According to analyst ratings and projections for CKPT, Checkpoint Therapeutics, Inc. shares are anticipated to increase by +3.60%, potentially reaching $4.42 per share by June 13, 2025. Short-term technical indicators currently suggest a neutral sentiment for CKPT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the CKPT stock forecast, now is a good time to buy CKPT stock because its current trading price is -2.64% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CKPT covering social and institutional perspectives.
CKPT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CKPT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 70.98% to 87.26%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 58.46%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.38%, maintains a neutral outlook for the long term. Insights into CKPT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Checkpoint Therapeutics, Inc. Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, Checkpoint Therapeutics, Inc. (CKPT) is positioned to show a strong performance in July 2025. The price is predicted to move between $12.93 and $14.86, settling at an average of $14.08. This could translate to a +230.52% gain.
August 2025
Based on current market signals, Checkpoint Therapeutics, Inc. is projected to trend august 2025. We forecast a trading range from $13.08 to $15.13, with a likely average price of $14.10. Investors could expect a potential return of +230.99%.
September 2025
Our predictive algorithms indicate Checkpoint Therapeutics, Inc. stock may see a shift in September 2025. The expected range spans $13.31–$16.54, with an average target of $14.89. This represents a positive outlook and a possible gain of +249.53%.
October 2025
Analyzing established trends, Checkpoint Therapeutics, Inc. looks set to move in October 2025. Projections place the stock between $14.61 and $19.64, averaging around $17.83. This suggests a +318.54% gain from current levels.
November 2025
Market indicators suggest Checkpoint Therapeutics, Inc. could experience notable changes during November 2025. Prices could fluctuate within $14.56 to $24.67, with a midpoint forecast of $18.71. The stock might deliver a +339.20% gain.
December 2025
Forecasting for December 2025, models estimate that Checkpoint Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $18.27 and $25.64, averaging $21.83. This signals a positive trajectory with potential returns around +412.44%.
January 2026
According to our latest forecast models, Checkpoint Therapeutics, Inc. (CKPT) is positioned to show a strong performance in January 2026. The price is predicted to move between $15.11 and $27.13, settling at an average of $21.45. This could translate to a +403.52% gain.
February 2026
Based on current market signals, Checkpoint Therapeutics, Inc. is projected to trend february 2026. We forecast a trading range from $13.62 to $22.19, with a likely average price of $17.52. Investors could expect a potential return of +311.27%.
March 2026
Our predictive algorithms indicate Checkpoint Therapeutics, Inc. stock may see a shift in March 2026. The expected range spans $14.26–$24.12, with an average target of $19.38. This represents a positive outlook and a possible gain of +354.93%.
April 2026
Analyzing established trends, Checkpoint Therapeutics, Inc. looks set to move in April 2026. Projections place the stock between $11.71 and $26.33, averaging around $17.21. This suggests a +303.99% gain from current levels.
May 2026
Market indicators suggest Checkpoint Therapeutics, Inc. could experience notable changes during May 2026. Prices could fluctuate within $16.07 to $33.06, with a midpoint forecast of $23.09. The stock might deliver a +442.02% gain.
CKPT's history of dividends and stock splits also plays a role in long-term investor confidence.

